Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 3 Medulloblastoma 2 Glioma 2 Diffuse Intrinsic Pontine Glioma 2 Xanthomatosis, Cerebrotendinous 1 Recurrence 1 Oligodendroglioma 1 Melanoma 1 Influenza, Human 1 Advanced Fallopian Tube Carcinoma 1

Interventions

Temozolomide 44 Radiotherapy 20 Magnetic Resonance Spectroscopy 13 Irinotecan 13 Carboplatin 11 Bevacizumab 11 Filgrastim 9 Surgical Procedures, Operative 7 Procarbazine 6 sargramostim 5 Vincristine 5 Imatinib Mesylate 5 Etoposide 5 Erlotinib Hydrochloride 5 Carmustine 5 Biopsy 5 etoposide phosphate 4 Peripheral Blood Stem Cell Transplantation 4 Lomustine 4 Immunohistochemistry 4 Cyclophosphamide 4 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 4 temsirolimus 3 poly ICLC 3 aldesleukin 3 Thalidomide 3 Surveys and Questionnaires 3 Radiation 3 Polymerase Chain Reaction 3 Gadolinium DTPA 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Oligodendroglioma × Diphtheria-Tetanus Vaccine × Clear all

NCT06254326 2026-05-27

ADAGiO

University of Florida

Phase 1 Recruiting

Brain Neoplasms, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡